Results 41 to 50 of about 24,809 (145)
Co‐infection of Hepatitis A and E With Atypical Manifestation: A Case Report
Clinical Case Reports, Volume 14, Issue 6, June 2026.ABSTRACT Hepatitis A virus (HAV) and hepatitis E virus (HEV) are common causes of acute viral hepatitis in developing countries where inadequate sanitation and contaminated water supplies facilitate fecal–oral transmission. Although both infections are usually self‐limiting, co‐infection may result in atypical presentations and pose diagnostic ...
Umaimah Batool Mirza +4 more
wiley +1 more source
Management of Acute Cholecystitis
The Korean Journal of Gastroenterology, 2018 Acute cholecystitis is a common serious complication of gallstones. The reported mortality of acute cholecystitis is approximately 3%, but the rate increases with age or comorbidity of the patient. If appropriate treatment is delayed, complications can develop as a consequence with a grave prognosis.
Seung-Ok Lee, Sung Kyun Yim
openaire +3 more sources
ω‐3PUFAs Inhibit Gallbladder Cancer Through Enhancing STK31 Methylation
Molecular Nutrition &Food Research, Volume 70, Issue 11, 15 June 2026.ABSTRACT Gallbladder cancer (GBC) is an aggressive malignancy with limited treatment options. ω‐3PUFAs have known anticancer activity, but their role in GBC remains unclear. The anti‐GBC effects of ω‐3PUFAs (DHA/EPA) were evaluated using in vitro assays and mouse xenograft models.
Shuang‐Xing Li +16 more
wiley +1 more source
Pharmacology Research &Perspectives, Volume 14, Issue 3, June 2026.ABSTRACT While the efficacy of canakinumab, an anti‐interleukin‐1β monoclonal antibody, is well‐established, its safety profile, particularly across different age groups, remains inadequately explored. Using the FDA Adverse Event Reporting System (FAERS) database, this study evaluated postmarketing safety by analyzing adverse event (AE) reports from ...
Youyang Wang +3 more
wiley +1 more source
United European Gastroenterology Journal, Volume 14, Issue 5, June 2026.ABSTRACT Background Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) are widely prescribed for type 2 diabetes mellitus (T2DM) because of their benefits in glycemic control, weight reduction, and cardiovascular outcomes. This study evaluated the risk of gallbladder disease among diabetic patients treated with GLP‐1 RAs.
Mohamed H. Eldesouki +7 more
wiley +1 more source
Contact Dermatitis, Volume 94, Issue 6, Page 677-688, June 2026.This study provides reassuring evidence in favour of early skin testing in patients with SCARs, argues against the necessity of a 6‐month delay, and underscores the pivotal role of oral provocation tests in the safe reintroduction of essential therapies. ABSTRACT Background Identifying and discontinuing the offending drug(s) in severe cutaneous adverse
Zohra Chadli +8 more
wiley +1 more source
Pediatric acute cholecystitis: Risk factors and outcomes. [PDF]
World J Clin PediatrBurjonrappa SC, Blamon F, Hurley SP.
europepmc +1 more source
Evaluation of microbiological cultures in patients with acute cholecystitis. [PDF]
Front SurgVáczi D +9 more
europepmc +1 more source